Skip to content
MedsAcross

Medicine

Digoxin 0.5 mg/2 mL injection

Digoxin · Intramuscular, intravenous
Available on requestPrescription onlyUS FDAGeneric name

Digoxin 0.5 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20˚ to 25˚C (68˚ to 77˚F), excursions permitted to 15˚ to 30˚C (59˚…

Key facts

Active ingredient (INN)
Digoxin
Brand
Sold under the generic name
Strength
0.5 mg/2 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
25 ampules of 2 mL, 5 ampules of 2 mL, 2 mL and 3 more
Manufacturers
Hikma PharmaceuticalsCardinal HealthHealthFirstHenry ScheinProPharma Distribution
Origin register
US FDA, United States
Storage
Store at 20˚ to 25˚C (68˚ to 77˚F), excursions permitted to 15˚ to 30˚C (59˚ to 86˚F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01AA05 Digoxin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 October 1975
Identifiers
RxCUI 104208DailyMed set ID 6aba2b38-5de0-4813-9775-39d87613893d, 98d2ad5b-9ffa-4456-9a01-567636c3a4d2, 3933b07f-5857-4a80-b502-e3214bdf9330 +3NDC 55154-5106, 0404-9850, 0641-1410 +3Application ANDA083391

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
25 ampule in 1 carton / 2 mL in 1 ampule0641-1410-35Hikma Pharmaceuticals24 October 1975
25 ampule in 1 carton / 2 mL in 1 ampule0641-6184-25Hikma Pharmaceuticals24 October 1975
5 ampule in 1 bag / 2 mL in 1 ampule55154-5106-5Cardinal Health28 June 2011
2 mL in 1 ampule51662-1217-1HealthFirst13 September 2018
1 ampule in 1 bag / 2 mL in 1 ampule0404-9850-02Henry Schein10 January 2022
2 mL in 1 ampule84549-410-35ProPharma Distribution11 December 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 16 November 1954Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Digoxin

Clinical summary

Digoxin is a cardiac glycoside indicated for treatment of mild to moderate heart failure in adults, among other approved uses. It is available as tablets, injection and oral solution for intramuscular and intravenous use. MedsAcross supplies Digoxin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Digoxin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Digoxin 0.5 mg/2 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.